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The differentiation and proliferation of hematopoietic cells are regulated by a com-
plex system of cell-cell interactions and soluble growth factors. Many of the mature
cells are short-lived and need to be constantly replenished from earlier progenitors
and stem cells. Pluripotent hematopoietic stem cells are defined as cells that give
rise to all cells in the myeloid, erythroid, and lymphoid lineages and also have self-
renewal capacity. The events that control self-maintenance of stem cells and induc-
tion of differentiationinto more mature restricted hematopoieticprecursors and sub-
sequently into mature cells are currently not well understood. The analysis of these
regulatory interactions has been hampered by the complexity of the hematopoietic
tissues, the low frequency of the relevant cells, and the heterogeneity of the regula-
tory factors.
Many of the factors that regulate the differentiation and proliferation of hemato-
poietic cells have recently become available in recombinant and purified form (for
review see reference 1). Several different growth factors can be discriminated by their
activities (2). When mouse bone marrow cells are grown in semi-solid medium in
the presence of macrophage colony-stimulating factor (M-CSF)' the resulting colo-
nies consist predominately ofmacrophages (3). Similarly, granulocyte-CSF (G-CSF)
and erythroprotein (EPO) seem to be lineage specific (4, 5). Most colonies induced
by GM-CSF consist of granulocytes and macrophages, but sometimes eosinophils
and mixed colonies are found(6-8). IL-5 (Eosinophil-CSF [Eo-CSF]) inducesdifferen-
tiation of bone marrow cells into eosinophils and also acts on B lymphocytes (9-11).
IL-3 (multi-CSF) stimulates single lineage colonies of many myeloid and erythroid
cells and also induces multilineage colonies containing several different cell types
(12-15). IL-3 supports the short-term survival of myeloid/erythroid-restricted pro-
genitors in vitro (14) that give rise to in vivo spleen colonies (CFU-S). On the basis
of these findings, a hierarchical modelhas been proposed that discriminatesbetween
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early- and late-acting factors (1, 2, 16, 17) . It suggests that multipotent and perhaps
even pluripotent hematopoietic stem cells may be responsive to IL-3. GM-CSF could
act on a multipotent progenitor, more restricted than the progenitor responsive to
IL-3 . G-CSF, M-CSF, and IL-5(Eo-CSF) are believed to stimulate late precursors
already committed to the respective lineages.
Several groups have conducted cell separation experiments to characterize the in-
terrelationship ofvarious CSF-dependent progenitor cells. To analyze early progen-
itors, cells from mice treated with 5-Fluorouracil (5-FU) have frequently been used.
5-FU has been reported to eliminate cycling cells and to affect early progenitors less
than late precursors (18, 19). Accordingly, M-CSF-responding cells seem to be more
sensitive to 5-FU than IL-3-responding cells (20). Furthermore, 5-FU treated tissues
have been reported to be enriched for mulipotential progenitors that may self-renew
in vitro (21), as well as high-proliferative progenitor cells (22-24) . The populations
containing these progenitors are reported to express the Thy-1 (23, 24) and/or Qam-
7 antigens (25). Both cell surface antigens are expressed on a variety ofbone marrow
cells, including murine hematopoietic stem cells (22, 26-30). Precursor cells responding
to purified M-CSF express lower levels of the Qam-7 antigen than cells that need
M-CSF plus another growth factor (25). The latter cells are primitive myeloid pro-
genitors and seem to be related to pluripotent stem cells (22). Elimination of Thy-1
expressing cells can eliminate the response to IL-3 (31). However, the precursors
that are stimulated by M-CSF are believed to express the Thy-1 antigen by some
authors (31) but not by others (32). Macrophage colonies are depleted in bone marrow
cells expressing Mac-1, and antigen found on mature macrophages (33, 34). Ideally,
experiments to identify growth factor responsive progenitors should involve highly
purified stem cells, progenitor and precursor cellswhich should be directly subjected
to defined growth factors. With few exceptions defined factors have not been used
in these studies. In addition, the enriched progenitor populations often included
lymphocytes, which could have produced endogenous growth factors.
We have recently described a population, Thy-V°T- B - G - M- cells, which con-
tain most, if not all, pluripotent hematopoietic stem cells found in bone marrow
and are depleted of mature lymphocytes and myeloid cells (27, 28). Thy-
V°T- B- G- M - cells, comprising 0.1 to 0.3% of normal mouse bone marrow, can
completely repopulate all the hematopoietic lineages in lethally irradiated mice and
are 100 to 200 fold enriched for clonogenic B, T and myeloid-erythroid progenitors
(27, 28, 35). In this paper we show that Thy-11°T- B - G- M- cells are 370-fold en-
riched for pluripotent hematopoietic stem cells, emphasizing that the Thy-
1 '°- B - G- M - population consists of a highly enriched population of stem cells. We
had also described another bone marrow-derived subpopulation, Thy-
1 - T- B- G" M - cells, characterized by the absence of Thy-1 and markers expressed
on mature myeloid and lymphoid cells (27). This population does not contain stem
cells, CFUS, or T cell precursors, but includes an early B cell precursor (27) . These
two populations, together with a third population, Thy-1+T+B+G+M + cells con-
sisting predominantly of mature T, B, and myeloid cells, represent most of bone
marrow. We have analyzed the response ofthesephenotypically distinct populations
to several defined growth factors. Our results indicate that purified progenitor popu-
lations can be used to test and extend the hierarchical model of growth factor action
directly.MULLER-SIEBURG ET AL.
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Materials and Methods
Mice.
￿
C57BL6-Ly5.2 (originally obtained from Dr. Boyse, Sloan-Kettering Hospital, New
York, NY) and BALB/c mice were bred at LillyResearch Laboratories. CBA/J and C57BL/6
mice were purchased from TheJackson Laboratory, Bar Harbor, ME. For some experiments
mice were injected intravenously with 5-FU (Sigma Chemical Co., St. Louis, MO) at a dose
of 150 mg/kg body weight 2 or 10 d before the experiment.
Antibodies.
￿
Rat mAb 31-11 is specific for the Thy-1 antigen (36), antibody 30H12 detects
the Thy-1.2 allele (37). RA3-6B2 detects the B220 antigen, expressed on mouse B lineage
cells beginning with the pre-B cell (38). M/70 is specific for the Mac-1 antigen on mouse
macrophages (34). A cell line secreting antibody RA3-8C5, specific for the Gr-1 antigen on
granulocytes (39) and eosinophils, was kindly provided by Dr. R. Coffman (DNAX Research
Institute, Palo Alto, CA). Mature T cells were detected with antibodies GK1 .5 and 5.3-6.72,
which detect the L3T4 (CD4) antigen (40) and the Lyt-2 (CD8) antigen (37). An antibody
specific for the Ly5.2 antigen, expressed on most white blood cells of C57BL6-Ly5.2 mice,
was purchased from New England Nuclear (Boston, MA).
CellSeparations.
￿
Sorting ofbone marrow cells was done as described previously (27). Bone
marrow was obtained from the femurs of 3-wk-old mice. Iscove's modified Dulbecco's medium
supplemented with 5% FCS, penicillin, and streptomycin was used throughout the proce-
dure. Bone marrow cell suspensions (N5 x 10'/ml) were incubated with antiThy-1 antibodies
31-11 or 30H12. After washing, cells were incubated with FITC-labeled goat anti-rat anti-
bodies (Caltag, SouthSan Francisco, CA), washed again, and incubated with normal rat serum
(Cappel Laboratory, Cochranville, PA) to block free binding sites of the goat anti-rat anti-
bodies. A cocktail of RA3-6B2, RA3-8C5, M/70, GK1.5 and 5.3-6.72 antibodies, all bi-
otinylated, was added 1-2 min after addition of the rat serum. Biotinylated antibodies were
detected with Texas Red-coupled avidin (Cappel Laboratories). Cells were then resuspended
in Dulbecco's PBS supplemented with 3% FCS, 0.02% NaN3, and 20 wg propidium io-
dide/ml and were separated with a multi-laser cell sorter at the Flow Cytometry Laboratory
at the Salk Institute for Biological Studies (La Jolla, CA). Two argon lasers were used, one
was tuned to 488 nm to excite FITC and propidium iodide, the other was used to pump
a dye laser tuned to 590 nm for the excitation of Texas Red . A 5 mW HeNe laser is used
as a pulse delay monitor to time the charging of the droplets. A volumenometer (Coulter
Electronics, Hialeah, FL) in combination with forward and side scatter measurements pro-
vide accurate measurement of cell size. Data acquisition and display are via a modified ver-
sion of the LACEL soft- and hardware, interfaced to a Digital micro-11/73 computer. A detailed
description of the instrumentation will be published elsewhere (Trotter, J., manuscript in
preparation). Some separations were done with a FAGS IV (Becton Dickinson & Co., Moun-
tain View, CA), modified as described (41) and made available through the FAGS shared
users group at Stanford University. Sorted cells were at least 85% pure asjudged by a variety
ofcriteria, including reanalysis by cell sorter, restaining with independent cell surface markers
and morphological analysis (28).
CFU-SAssay.
￿
Sorted cell populations were routinely tested for the number ofday 10 CFU-S
to assess enrichment and purity. The assay was done as described previously (27, 42). Fre-
quency of CFU-S in Thy-1"T- B- G- M- was 1 in 30-60; Thy-1 - T- B- G- M- or Thy-
1' T` B' G' M' cells contained <1 CFU-S in 104 cells injected.
Source of Factors.
￿
Erythropoietin (step III) was purchased from Terry Fox Laboratories
(Vancouver, BC, Canada). Purified G-CSF was a gift from N. Nicola (Walter and Eliza Hall
Institute, Melbourne, Australia) and purified M-CSF was a gift of R. Shadduck (University
ofPittsburgh, School of Medicine, Pittsburgh, PA). DNAX Research Institute provided purified
rIL-3 (43) and provided rGM-CSF and IL-5 in the form of supernatants from Cos 7 cells
transfected with the GM-CSF cDNA clone (44) and the IL-5 cDNA, respectively (45). 1 U
of G-CSF, M-CSF, IL-3, and GM-CSF is defined as the amount of factor that stimulates
half-maximal [3H]thymidine incorporation of an appropriate factor-dependent cell line cul-
tured at 5 x 104 cells/ml. Each factor was then titered in the CFU-C assay and was gener-
ally used at twice the concentration required to stimulate optimal colony formation in methyl-
cellulose cultures.
Bone Marrow ColonyformingAssay (CFU-C).
￿
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populations were plated in 35-mm culture dishes (Falcon Labware, Oxnard, CA) containing
1 ml Iscove's Medium (Gibco Laboratories, Grand Isle, NY), 20% FCS, 5 x 10 -' M R-
mercaptoethanol, 0.8% (wt/vol) methylcellulose, supplemented with various growth factors,
as described previously (46). Colonies consisting of 50 or more cells were scored between
days 10 and 21 as indicated .
Radiobrotection Assay.
￿
8-10-wk-old C57BL/6 mice were lethally irradiated with 1,140 rad
(two times 570 rad at 190 rad/min from a Mark I ' ;'Cs irradiator, with 2-4 h between ir-
radiations). Mice were injected intravenously with graded doses of sorted or unseparated bone
marrow cells derived from Ly5 congenic C57BL6-Ly5.2 mice. Percent surviving mice was
determined 30 d after injection. All surviving mice were bled 5-8 wk after reconstitution
and their blood cells were stained for expression of the donor type Ly5.2 marker. Only mice
that showed the majority (>-80%) of white blood cells of donor type were considered in the
titration.
Results
Source ofStem Cells.
￿
Hematopoietic cells from normal bone marrow were sepa-
rated into three subpopulations as described previously (27). Fig. 1 depicts the popu-
lations obtained when bone marrow is stained simultaneously with an antiThy-1
antibody and a cocktail ofantibodies recognizing T, B, and myeloid-specific markers.
Population I consists predominantly of macrophages, granulocytes, eosinophils, T
cells, pre-B, and B cells. These cells are stained by one or more of the antibodies
we used and are summarily called Thy-1 ' T+ B' G' M' cells. Population II lacks all
markers we assayed (Thy-1 - T - B - G- M- ￿cells) and contains predominantly
erythrocytes and undifferentiated blast cells. Histological analysis of freshly sorted
Thy-1 - T- B- G- M - cells revealed 54% mature red blood cells, 20% nucleated red
blood cells, 24% undifferentiated blasts, 0.7% myeloblasts, 0.4% macrophages. Nei-
ther the Thy-1'T'B'G'M' nor the Thy-1 - T- B - G- M- population contains de-
tectable levels of stem cells or CFU-S (27). Population III, composing 0.1 to 0.3%
of bone marrow, is characterized by expression of low levels of Thy-1 and lack of
all other maturational markers. Sorted Thy-1'°T- B- G - M- cells are >98%
undifferentiated blast cells as determined by histological analysis. The Thy-
1'°T-B-G-M- population is -100-200-fold enriched for B and T lymphocyte pro-
genitor activity, and day 10 CFU-S (27, 28, 35) but is depleted ofday 8 CFU-S (Miiller-
Sieburg, C . E., manuscript in preparation). Furthermore, Thy-V°T- B" G- M- cells
contain most if not all pluripotent hematopoietic stem cells found in bone marrow.
Thy-1'°T" B- G- M - , but not Thy-1 - T - B- G- M - or Thy-1' T' B' G' M' cells, can
rescue lethally irradiated mice and repopulate all the hematopoietic cell lineages in
these mice (27, 28) .
The radioprotection assay is considered the most stringent assay for pluripotent
stem cells. To quantitate stem cells in the Thy-1'°T- 13 - G - M- population, the dose
of unseparated bone marrow cells and Thy-1'°T- B - G- M- cells needed to protect
irradiated mice was compared. We found that 3 .7 x 104 bone marrow cells are re-
quired to rescue and repopulate 50% of the mice, a dose that is in good agreement
with published data (47). In contrast, -100 Thy-1'°T- B- G- M - cells, representing
a 370-fold enrichment, sufficed (Fig. 2). This 370-fold enrichment parallels the en-
richment of Thy'°T- B - G- M- cells, which compose 0.1 to 0.3 % of bone marrow.
It also indicates that Thy-1'°T- B - G - M - cells represent a very highly enriched stem
cell population. In agreement with previous studies (27), the Thy-1 - T- B - G- M-
and Thy-1' T' B' G' M' cells were unable to rescue lethally irradiated mice (dataMULLER-SIEBURG ET AL .
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FIGURE 1 .
￿
FAGS profile of mouse bone marrow cells . Cells were reacted simultaneously with
biotin-labeled antibodies specific for B220, Mac-1, Gr-1, L3T4, and Lyt-2 (see Materials and
Methods for details o£ antibodies and their specificities) all present in a cocktail and detected
with Texas Red-conjugated Avidin . Thy-l-expressing cells were labeled with antibody 31-11 de-
tected with FITC-labeled goat anti-rat antibodies . The windows inA are labeled to indicate our
designation for each population of cells . Population I : consists predominantly of pre-B and B
cells, T cells, macrophages, and granulocytes . These cells express antigens detected by one or
more of the antibodies used and are thus designated Thy-1' T' B' G'M' cells . Population I com-
poses 75-85% of total bone marrow . Population II : Thy-1 -T-B-G-M- cells that lack all markers
we used and represent 15-20% of bone marrow. Population III : cells expressing low levels of
Thy-1, designated Thy-1"°T-B-G-M - cells, which make up 0.1-0 .3% ofbone marrow. B shows
the cell size ofbone marrow, as determined with a Coulter volumenometer, plotted against inten-
sity of FITC staining. For the purpose ofeasier identification we have marked with : N . The cells
that fall into window III in A and represent Thy-1 1"T-B-G -M- cells . Note that these cells are
predominantly small. BothA and B depict on theirx andy axis the corresponding histograms
C is a three-dimensional depiction of the data in A, adding a frequency parameter.
not shown) . Interestingly, some mice injected with low doses of either unseparated
bone marrow or Thy-V°T-B -G-M- cells showed predominant repopulation with
host-type cells (data not shown) . Survival of these mice (which are not included in
the titration depicted in Fig. 2)wasdependent on injection ofa source of stem cells,
as mice injected even with high doses of Thy-1 -T-B-G-M- cells (containing my-1830 GROWTH FACTOR RESPONSE OF HEMATOPOIETIC PROGENITORS
FIGURE 2 .
￿
Titration of radioprotecting cells. Graded doses of either unseparatedbone marrow
(O) or sorted Thy-1"T-B-G-M- cells (/), both derived from C57BL6-Ly5,2 mice, were in-
jected into lethally irradiated congenic C57BL/6 mice (Ly5 .1) . Groups of six mice were injected
for each cell concentration . Surviving mice (>30 d) include only mice that contained a majority
of donor cells (Ly5.2) in theirblood 5-8 wk after reconstitution . The dose at which 50% of the
animals survived is indicated in the figure.
eloid and B lymphocyte progenitors and immature erythrocytes) did not survive
more than 2 wk .
The Thy-]"T-B-G-M- and Thyl-T-B - G-M- Populations Contain Distinct IL-
3-responsive Progenitors. IL-3 interacts with a variety of cells. It supports the prolifer-
ation of myeloid and mast cell lines and stimulates the generation of single lineage
and mixed colonies from bone marrow cells (13, 14, 48) . When Thy-1 1°T- B -G-M-
cells are stimulated with recombinant purified IL-3 in semi-solid methylcellulose
medium, they give rise to colonies with high frequency. One in seven Thy-
1 1°T- B-G-M- cells proliferated and differentiated upon stimulation with IL-3,
representing a 100-fold enrichment over unseparated bone marrow (Table 1) . Anal-
ysis of the cellular composition of Thy-ll°T-B-G-M - derived colonies reveals a
I
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TABLE I
IL-3-dependent Colony Formation by Sorted Bone Marrow Subpopulations
Sorted cell populations were stimulated with rIL-3 (400 U/ml) in methylcelullose . Erythropoie-
tin (1 U/ml) was added after 4 d of culture to promote erythroid development .
Colonies counted were standardized to 104 cells seeded to allow better comparison and
represent the mean of three to nine individual experiments ± SD . Duplicate culture were
scored at day 10 of each individual experiment . Cells actually seeded per plate :
Thy-l"T- B-G-M- : 100-5,000; Thy-1"T-B-G-M- : 1-2 x 10 4 ; Thy-1'T+B+G'M+ :
2-10 x 104 ; bone marrow : 10 5 .
Frequencies are calculated on the basis of the mean .
Refers to both pure and mixed erythroid colonies .
Cells
Percent of
bone marrow
Colonies per
Total
104 cells
Percent
erythroids frequency 1 1
Thy-1 1°T -B-G-M- 0.1-0 .3 1,381 ± 244 35 7
Thy-l -T-B- G-M- 15-20 27 ± 14 3 370
Thy-1' T+ B'G+M+ 75-85 5 ± 3 0 2,000
Bone marrow 100 15 + 11 20 666MULLER-SIEBURG ET AL,
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TABLE II
Cellular Composition of IL-3-dependent Colonies
Sorted cell populations were stimulated with IL-3 and erythropoietin as detailed in Table I. Colonies were
counted and sequentially picked for differential staining at day 10.
' Abbreviations used: G, granulocytes; M, macrophages ; E, erythrocytes; Eo, cosinophils.
1 Mixed colonies contained two or more different lineages other than GM; 80% of the mixed colonies con-
tained erythrocytes, 15% megakaryocytes .
large proportion ofmixed colonies, as expected from pluripotent or multipotent stem
cells (Table II). 40-60% of the colonies contained two or more cell types other than
granulocytes and macrophages (Table II). In unseparated bone marrow only 10-25
of the colonies were mixed (Tables I and II).
Thy-1 - T- B- G- M - cells also respond to IL-3 (Table I). The frequency ofclono-
genic cells in the Thy-1 - T- B - G- M- population is -50 times lower than in Thy-
1 1°T- B- G - M- cells. Furthermore the colonies obtained from the Thy-1 - T-
B- G- M - population are almost exclusively restricted to the granulocyte and mac-
rophage lineages (Table II). In particular, Thy-1 - T- B - G - M- cells are depleted of
progenitors that can differentiate into erythrocytes or mast cells in our culture con-
ditions. These progenitors are enriched in the Thy-1"T- B - G - M - population. This
clearly shows that bone marrow contains at least two distinct early progenitors capa-
ble of proliferating and differentiating upon stimulation with IL-3, namely cells
with the phenotype Thy-1 1°T- B- G- M- , which consist of or coenrich with pluripo-
tent stem cells, and a more mature, restricted progenitor lacking Thy-1. Thy-
1"T- B- G- M - cells make up 15-20% of bone marrow (Fig. 1). Thus, despite the
low frequency of responder cells, Thy-1 - T - B- G- M - cells contribute two to three
times more colonies to the total IL-3 response of bone marrow than Thy-
1 1°T- B - G- M- stem cells (Table I).
The large Thy-1+T+B+G'M+ population was depleted of IL-3-responsive colony-
forming cells when compared with unseparated bone marrow, Thy-1 "'T- B- G- M - ,
or Thy-1 - T- B - G - M- cells. We have, however, found some colonies derived from
this Thy-1 + T+B'G'M+ population (Table I). Due to the large size of this popula-
tion these colonies may represent a significant proportion of the total IL-3 response
of bone marrow. Whether these colonies are derived from yet a third, possibly novel
progenitor or, as the low frequency and the restricted cellular composition of the
colonies suggests (Table II), sorter contamination by Thy-1 - T- B - G - M- cells, is
the subject of current studies.
Interestingly, the majority of erythroid cells derived from sorted subpopulations
are found in mixedcolonies, observable around 10 d ofculture (Table III). In several
Colony
type' Thy-l"'T- B- G - M - Thy-1 - T- B- G"M- Thy-1'T*B*G'M'
Bone
marrow
G 8 3 2 7
M 18 27 2 14
GM 38 32 7 24
E 1 0 0 1
Eo 5 1 0 4
Mast 1 0 0 2
Mixedl 42 1 0 151832
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TABLE III
IL-3-responsive Cells are Affected by 5-FU
Bone marrow cells and Thy-11°T- B- G- M- cells were derived from mice that
had been injected with 150 mg of 5-fluorouracil per kilogram body weight at
3 wk of age 2 or 10 d before the experiment . Cells were stimulated with IL-3
and erythropoietin as detailed in Table I .
experimentswe wereunable to identify restrictederythroid precursors, termed CFU-E,
in any of the bone marrow subpopulations we tested (data not shown). These
precursors, which differentiate upon stimulation with EPO alone, were readily ob-
tained from unseparated bone marrow in 4-6-d-old cultures, even if the cells were
incubated with antibodies and run through the cell sorter (data not shown) . This
indicates that CFU-E are not damaged by the staining or sorting procedure. It is
conceivable that CFU-E do need, in addition to EPO, interaction with a yet
unidentified cell to proliferate of differentiate. We are currently investigating this
possibility by mixing of sorted cell populations.
IL-3-responsive Cells in Bone Marrow of 5-FU-treated Mice.
￿
While most Thy-
1 1°T-B"G- M- cells are small and resting cells (Fig. 1), ti1517o ofthese cells are in
the G2 or M phase ofcell cycle (Tidmarsh, G. A., S. Heimfeld, G. J. Spangrude,
I. L. Weisman, and C. E. Muller-Sieburg, manuscript submitted for publication).
Thedrug5-FUisreportedto eliminatecyclingcells and isfrequently used in studies
ofearly hematopoiesis. It seems to affect late precursors while sparing early progen-
itors to some extent (18-24). To assess the effect of 5-FU on the IL-3 response of
Thy-1 1°T- B"G- M- cells, we used bone marrow of mice injected with 5-FU 2 or
10 d before the experiment. The depletion oflate precursors seems to be most ap-
parent 1-2 d after in vivo drug treatment (18, 52). 10 d after 5-FU administration,
bone marrow contains a large compartment of Thy-l-expressing cells (other than
T cells), many of which are large cycling cells. However, the Thy-1 1°T- B-G- M-
population is only slightly increased (Muller-Sieburg, C., unpublished observation).
Interestingly, Thy-11°T- B-G-M- cells from mice treated with 5-FU 2 d before their
isolation, have lost the ability to respond to IL-3 (Table III). This indicates that
predominantly the cycling cells in the Thy-1 1°T-B-G- M- population can be stimu-
lated by IL-3. The IL-3 response ofThy-1 1°T-B-G- M- cells is completely restored
in the regenerating day 10 post-5-FU bone marrow (Table III). These data are in
agreementwith previous reports, showingthat large Thy-l-expressing cellscan give
rise to mixed colonies (24).
The Thy-1 - T-B-G-M- Population Contains M-CSF, G-CSF, and IL-5 Responders.
While Thy-11°T-B- G- M- cells from normal bone marrow respond with a very
Source of
bone marrow Cell population
Colonies per
104 cells
Normal Bone marrow 14 + 5
Thy-1"T- B- G- M- 1,300 ± 260
Day 2 5-FU' Bone marrow 3 ± 2
Thy- l"T- B- G- M- <5
Day 10 5-FU' Bone marrow 43 ± 21
Thy-O°T- B- G- M- 1,750 t 290MULLER-SIEBURG ET AL.
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TABLE IV
Response of Sorted Bone Marrow Subpopulations to IL-3, IL-5,
M-CSF, G-CSF, and GM-CSF
Sorted cell populations were stimulated with indicated growth factors (all used at 400 U/ml) in methylcellu-
lose. Erythropoietin (1 U/ml) was added after 4dand colonies were counted after 10 d of culture. Data ± SD
oftwo typical experiments are presented. Data are standardized to colonies per 104 cells; for details see Ta-
ble I.
high frequency to IL-3, few or none react to M-CSF, G-CSF or IL-5 (Eo-CSF).
The majority of the precursors that give rise to acolony in response to these factors
are found in the Thy-1 -T-B-G-M- population (Table IV). Thus, multipotent pro-
genitors and restricted precursors can be separated based on the expression of the
Thy-1 antigen. Furthermore, our data confirm that M-CSF, G-CSF, or IL-5 alone
do not induce proliferation of stem cells but act on early precursors with restricted
differentiation potential.
The enrichment forprecursors activated by either G-CSF, M-CSF, or IL-5 within
the Thy-1 -T-B-G- M- population is two to threefold when compared with unsepa-
rated bone marrow. However, 70-80Fo of the Thy-1 -T-T-B-G` M- population are
mature and nucleated erythrocytes. Thus, the actual enrichment, based on white
cell count, is considerably higher and can be calculated to be 10-15-fold. Thus, most
of the hematopoietic precursors that are stimulated by M-CSF, G-CSF, or IL-5 are
characterized as undifferentiated blast cells that lack Thy-1, B220, Mac-1, Gr-1, L3T4
(CD4), and Lyt-2 (CD8) antigens and can be enriched from normal bone marrow
by virtue of this phenotype.
Progenitors and precursors that could form colonies upon stimulation with all
the growth factors we have tested were depleted in the Thy-1+T+ B+ G+M+ popu-
lation. However, a few colonies were obtained consistently from the Thy-
1 +T+B+G+ M+ population (Table IV). In an attempt to characterize further the
cells responding to G-CSF we started to dissect the Thy-1+T+B+ G+ M+ population.
We found that cells responding to G-CSF are depleted both in the Gr-1- or Thy-1-
expressing bone marrow subpopulations (datanot shown). A more detailed analysis
is necessary to resolve the question whether the colonies obtained from the Thy-
1 +T+ B+ G+ M+ population are due to a low level of sorter contamination by Thy-
1 -T-B-G- M- cells or whether they represent a distinct progenitor.
Whetherthe growth factors anlayzed here act on the same or on different progen-
itors remains to be clarified. When we stimulated Thy-1 - T-B-G-M- cells with
Growth
factor Thy-1"T- B- G- M- Thy-1 - T- B-G- M- Thy-1' T`B` G' M' Bone marrow
IL-3 1,360 1 74 32 ± 4 5 ± 2 10 ± 1
GM-CSF 112 1 30 15 1 3 3 ± 1 6 ± 0.4
M-CSF 0.3±0.3 24 1 1 6±2 8±0.1
G-CSF 0 10 5±2 1 ± 1 2±0.3
None 0±0 0±0 0 f 0 0.6 1 0.4
IL-3 1,260 ± 120 26 ± 1 ND 8 + 0.5
GM-CSF 90 ± 10 21 ± 1 5 ± 0.5
IL-5 0±0 5.5 ± 1 1 ±0.1
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TABLE V
Additive Effects of Stimulation by Two Growth Factors
Exp.
￿
Growth factor(s)
￿
Thy-0°T- B- G- M- ￿Thy-1- T- B- G- M-
Sorted cell populations were stimulated with indicated growth factors (all used at 400 U/ml)
in methylcellulose. Erythropoietin (1 U/ml) was added after 4 d and colonies were counted
after 10 d of culture . Colonies are standardized to 104 cells input (for details see Table 1). Con-
centration of growth factors in mixing experiments was the same as in individual application
(400 U/ml each).
a combination of IL-3 and G-CSF, or M-CSF, or GM-CSF, the numberofcolonies
obtained was roughly additive. This indicates that IL-3 acts ondifferent progenitor
cellsthan G-CSF, M-CSF or GM-CSF. A similar additive effect is found when Thy-
1 -T-B-G-M- cells are stimulated simultaneously with M-CSF and GM-CSF
(Table V). Addition of M-CSF or G-CSF to IL-3 does not increase the number of
IL-3-driven colonies in the Thy-11°T-B- G-M- population but increases the size
ofthe colonies (data not shown). This again emphasizes that M-CSF and G-CSF
do not act on stem cells but on their progeny.
Response ofSorted Populations to GM-CSF.
￿
Progenitors respondingto GM-CSF are
found in all three populations (Table IV). The progenitors that proliferate in re-
sponse to GM-CSF are depleted in the Thy-1+ T+ B+G+M+ population but are en-
riched in the Thy-1- T-B- G- M- population to the same extent as G-CSF, M-CSF,
or IL-5-reactive cells. In contrast, GM-CSF stimulates a small subset (<10%) ofThy-
11°T- B-G- M- cells. Slighty more colonies are obtained from Thy-11°T- B-G-M-
cells cultured in the presence ofboth IL-3 and GM-CSF than with IL-3 alone, indi-
cating that these factors may act on distinct progenitors (Table V). The analysis of
the cellular composition ofthe colonies derived from Thy-11°T-B-G-M- cells after
GM-CSF stimulation reveals 10% mixed colonies(Table VI). TheGM-CSF response
ofThy-1-T-B-G-M- cells appears to be restricted to the macrophage and granu-
locyte lineages. Consistent with previous reports (7, 8), our datasuggestthat GM-CSF
can stimulate a subset of multipotent progenitors. Like IL-3, GM-CSF probably
can act on at least two distinct progenitors in bone marrow, found in the Thy-
11°T- B-G- M- and in the Thy-1-T-B-G-M- populations, respectively.
Discussion
Thy-1t°T-B-G-M- Cells Are Highly Enrichedfor Pluripotent Stem Cells and Contain a
High Frequency ofIL-3-responsive Cells. We have previously shown that a small sub-
population of normal mouse bone marrow, Thy-11°T- B-G-M- cells, contains
pluripotent hematopoietic stem cells that repopulate andallow the survival oflethally
irradiated mice (27, 28). Here we have quantitated stem cell activity in a radio-
1 IL-3
GM-CSF
M-CSF
G-CSF
1,390 ± 60
90 + 20
0 + 0
0+0
35 ± 5
15 + 3
26 + 2
6+ 1
2 IL-3 + GM-CSF 1,500 ± 80 49 ± 6
IL-3 + M-CSF 1,340 ± 50 53 ± 4
IL-3 + G-CSF 1,290 ± 60 43 ± 5
M-CSF + GM-CSF 110 + 20 38 + 4MULLER-SIEBURG ET AL.
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TABLE VI
Cellular Composition of GM-CSF-dependent Colonies
Sorted cell populations were stimulated with GM-CSF (400 U/ml) in methyl cellulose. Erythropoietin (1
U/ml) was added after 4 days of culture to promote erythroid development. Colonies were counted and
sequentially picked for differential staining at day 10.
' Mixed colonies contained two or more different lineages other than GM .
protection assay and demonstrate that sorted Thy-1 1°T- B- G - M - cells are 370 fold
enriched when compared to unseparated bone marrow. Roughly 100 Thy-
1 1°T- B- G- M - cells were needed to protect 50°Jo of lethally irradiated mice. Pre-
viously reported enrichments for pluripotent stem cells in mice (47) and rats (48)
are 180- and 350-fold, respectively. Interestingly, -3,000 rat stem cells, which had
been 350-fold enriched, were needed to protect lethally irradiated rats (48). The shape
of the titration curve of stem cells both in mice (Fig. 2 ; reference 47) and in rats
(48) seems to be similar. Thus, the requirement for significantly different doses of
rat versus mouse pluripotent stem cells (of similar enrichment) may indicate that
the nadioprotection assay does not accurately measure frequencies. The absolute fre-
quency of pluripotent hematopoietic stem cells in murine bone marrow remains yet
to be determined.
We also show that sorted Thy-11°T- B - G- M- cells are 100-fold enriched for pro-
genitors that can proliferate and differentiate upon stimulation with recombinant
purified IL-3 . Many of the colonies obtained from Thy-1 1°T- B- G- M - cells con-
tain several cell lineages as expected from multipotent or pluripotent stem cells. Thy-
11"T- B - G- M- cells are >987o undifferentiated blast cells (46), are depleted of ma-
ture myeloid, erythroid, and lymphoid cells, lack day 8 CFU-S, and by this criteria
are a fairly homogeneous population. Whether the Thy-1 1°T- B - G- M- cells that
respond to IL-3 are pluripotent stem cells or multipotent stem cells that coenrich
in this population is difficult to say. 5-FU, early after administration, depletes IL-3-
responsive cells, indicating that these cells reside in the cycling compartment of the
Thy-1 1°T- B- G - M - population (Table III) . 5-FU appears to spare some, but not
all day 15 CFU-S (18, 19) indicating that IL-3-responsive Thy-1 1°T- B- G- M - cells
are distinct from CFU-S. However, little is known about the status of the pluripotent
stem cell (as measured by the radioprotection assay) in 5-FU-treated bone marrow.
Thus, further analysis is needed to resolve the question whether IL-3 acts directly
on pluripotent stem cells. Clearly, Thy-11°T- B - G - M- cells represent a population
of primitive hematopoietic progenitors, which can differentiate into multiple lin-
eage with a high frequency upon stimulation by IL-3 .
Colony
type Thy-1 "'T- B- G- M- Thy-1- T- B- G- M- Thy-1' T' B' G' M`
Bone
Marrow
G 8 5 6 7
M 1 35 6 6
GM 33 37 8 25
E 4 0 0 2
Eo 0 0 0 0
Mast 0 0 0 0
Mixed' 5 0 0 21836 GROWTH FACTOR RESPONSE OF HEMATOPOIETIC PROGENITORS
It is difficult to deduce the origin of the single lineage colonies derived from
Thy-1°°T - B- G - M - cells upon IL-3 stimulation . It is possible that the Thy-
1 "°T" B - G - M - population contains a number of already committed precursor cells.
As detailed above, a sorted population is unlikely to be absolutely pure. Alterna-
tively, the single lineage colonies could be attributed to stochastic stem cell differen-
tiation . The stochastic model for stem cell differentiation, formulated by Ogawa et
al. (21, 50, 51), suggests that pluripotent stem cells can commit directly to either
multipotent or monopotent restricted precursors randomly.
We have previously shown that Thy-l'°T- B - G- M- cells give rise with a high fre-
quency (20%) to colonies containing mast cells (46). We here confirm this result
and demonstrate that mast cells are derived from Thy-1 - T - B- G - M - cells but not
from Thy-1 + T* B* G* M+ or Thy-1 - T- B - G- M- cells (Table II). Even after
prolonged culture (3 wk) in the presence of IL-3, mast cells were not found in 126
colonies derived from Thy-1 - T- B - G - M- cells (data not shown). This indicates
that the precursors for the mast cell lineage and the macrophage-granulocyte lineages
may split relatively early in differentiation, possibly at the level ofa mulipotent stem cell.
Approximately 1 % of Thy-1 '°T - B- G- M - cells respond to GM-CSF. We can
presently not discriminate whether these GM-CSF responders represent a subset
of pluripotent or multipotent stem cells or whether they are derived from a few re-
stricted progenitors included in the Thy-l'°T- B - G" M- population. That the IL-
3-responding cells may be distinct from the GM-CSF responder cells is indicated
by the observation that the combination of these factors results in roughly additive
numbers of colonies. GM-CSF induces a significant number o£ mixed colonies in
the Thy-1'°T- B- G - M - but not in the Thy-1 - T- B- G- M - population (Table VI),
suggesting that GM-CSF, like IL-3, can stimulate two distinct progenitors distin-
guished by the presence or absence of the Thy-1 cell surface molecule. Thus, in agree-
ment with previously published data (23, 24, 26-32), our experiments demonstrate
that expression oflow levels ofThy-1 characterize progenitors with extensive prolifer-
ative capacity and multiple differentiation options.
Thy-1 - T-B-G-M- Cells Contain Restricted Precursors.
￿
The Thy-1 - T- B - G- M -
population contains cells able to proliferate in response to all the growth factors tested.
In particular, this population contains a high proportion of those cells in normal
bone marrow that differentiate and proliferate upon stimulation with either M-CSF,
G-CSF, or IL-5 (Eo-CSF). Our results confirm the findings of others, that most M-
CSFresponding cells do not express the Mac-1 (33) or Thy-1 (32) antigens. We ex-
tend these data to show that neither M-CSF nor G-CSF -nor IL-5-responding cells
express Thy-1, Mac-1, Gran-1, B220, or T cell marker and that these characteristics
can be used to enrich the responder cells. Currently we are testing a panel of mAbs
raised against Thy-1 - T- B- G - M- cells and hope to find antibodies that will allow
an even better enrichment. Furthermore, these antibodies might allow us to dissect
the Thy-1 - T- B - G - M- compartment in order to establish firmly whether distinct
or overlapping progenitor subsets respond to individual growth factors.
The Thy-1 - T- B - G - M- population also contains progenitors that proliferated
in response to IL-3 . These progenitors are restricted to the granulocyte and macro-
phage lineages and contribute the majority of IL-3-responding cellsin bone marrow.
Thus, the combined response of the Thy-l'°T- B - G- M - and Thy-1 - T- B - G- M -
populations would account for the large number of granulocyte and macrophage
colonies found in unseparated bone marrow upon IL-3 stimulation.MLTLLER-SIEBURG ET AL.
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Costimulation with IL-3 plus M-CSF or G-CSF resulted in increased colony forma-
tion, indicating that these factors act on distinct precursors contained in the Thy-
1 - T- B- G- M - population. A more detailed analysis is necessary to resolve this
issue. At this point it is tempting to conjecture a novel class of progenitors, already
committed to the macrophage/granulocyte lineage, that can be stimulated by IL-3
but not by GM-CSF, M-CSF, or G-CSF.
Few if any Thy-1i"T_B- G - M- cells formed colonies in response to M-CSF, G-
CSF, or IL-5 . This confirms the previously proposed model (2), that these factors
do not act on multipotent hematopoietic stem cells.
Occasionally, progenitors responsive to all the factors we tested were found in the
population of predominantly mature hematopoietic cells, the Thy-1' T' B' G' M'
population. It is possible that further analysis may show that this population con-
tains progenitors distinct from those in the Thy-1 - T- B- G- M - or Thy-11"T- B -
G - M - populations. Alternatively, as the low frequency of these progenitors and
their restricted differentiation capacity suggests, they may be due to low level sorter
contamination of the Thy-1' T' B' G' M' population by Thy-1 - T - B- G- M - cells.
Our attempts to dissect the Thy-1' T' B' G' M' compartment to further analyze
these progenitors cells have failed so far.
Several experiments indicate that the activation of primitive hematopoietic pro-
genitors requires more than one growth factor. IL-1 (hematopoietin-1), M-CSF, and
other known cytokines found in conditioned supernatant of a variety of sources may
act as necessary co-stimulators with IL-3 (20, 25, 52, 53). Thus, the bone marrow
subpopulations Thy-1- T- B- G- M- and Thy-1""T- B- G - M- , both enriched for
distinct hematopoietic progenitors, could prove valuable for the characterization of
novel growth factors and cofactors .
Summary
Three distinct hematopoietic populations derived from normal bone marrow were
analyzed for their response to defined growth factors. The Thy-1 1"T- B - G - M-
population, composing 0.2o7o of bone marrow, is 370-fold enriched for pluripotent
hematopoietic stem cells. The two other populations, the Thy-1 " T- B- G- M - and
the predominantly mature Thy-1' T' B' G' M' cells, lack stem cells. Thy-
P°T- B - G - M- cells respond with a frequency of one in seven cells to IL-3 in an
in vitro CFU-C assay, and give rise to many mixed colonies as expected from an
early mulipotent or pluripotent progenitor. The Thy-1 - T- B- G- M - population
also contains progenitor cells which responded to IL-3 . However, colonies derived
from Thy-1 - T- B - G- M- cells are almost exclusively restricted to the macro-
phage/granulocyte lineages. This indicates that IL-3 can stimulate at least two dis-
tinct clonogenic early progenitor cells in normal bone marrow: multipotent Thy-
P°T- B - G - M- cells and restricted Thy-1 - T- B - G- M- cells. Thy-1"'T- B - G- M-
cells could not be stimulated by macrophage colony-stimulating factor (M-CSF),
granulocyte CSF (G-CSF) or IL-5 (Eosinophil-CSF). The hematopoietic precursors
that react to these factors are enriched in the Thy-1 - T- G - B- M- population. Thus,
multipotent and restricted progenitors can be separated on the basis of the expres-
sion of the cell surface antigen Thy-1.
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